Sedana Medical AB (publ)
STO:SEDANA
Sedana Medical AB (publ)
Pre-Tax Income
Sedana Medical AB (publ)
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Pre-Tax Income
-kr9.9m
|
CAGR 3-Years
44%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Pre-Tax Income
kr1.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Pre-Tax Income
kr158.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Pre-Tax Income
kr176.9m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
Getinge AB
STO:GETI B
|
Pre-Tax Income
kr2.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Pre-Tax Income
kr684m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
Glance View
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
See Also
What is Sedana Medical AB (publ)'s Pre-Tax Income?
Pre-Tax Income
-9.9m
SEK
Based on the financial report for Dec 31, 2024, Sedana Medical AB (publ)'s Pre-Tax Income amounts to -9.9m SEK.
What is Sedana Medical AB (publ)'s Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
10%
Over the last year, the Pre-Tax Income growth was 83%. The average annual Pre-Tax Income growth rates for Sedana Medical AB (publ) have been 44% over the past three years , 10% over the past five years .
You don't have any saved screeners yet